AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVION LTD

0.083

0.000

Volume:43.28K

Turnover:3.59K

Market Cap:7.11M

PE:-0.68

High:0.087

Open:0.087

Low:0.082

Close:0.083

52wk High:0.200

52wk Low:0.075

Shares:85.65M

Float Shares:56.74M

Volume Ratio:0.78

T/O Rate:0.08%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.122

EPS(LYR):-0.122

ROE:-77.64%

ROA:-44.16%

PB:0.86

PE(LYR):-0.68

Loading ...

Overview Company News Filings

BRIEF-Invion Raises A$1.3 Million Through Convertible Note Offering

Invion Ltd - Raised a$1.3 Mln via Convertible Note Offering

THOMSON REUTERS

BRIEF-Invion Seeks Trading Halt

BRIEF-Invion Secures Non-Dilutive Funding From Hanlim Pharm And Korean Government Research Fund

Invion Ltd - Work Program Estimated to Be Worth up to a$2 Mln

THOMSON REUTERS

Invion Ltd - Non-Dilutive Funding Secured From Hanlim Pharm and Korean Govt Research Fund for Esophageal Cancer Preclinical Program

THOMSON REUTERS

BUZZ-Crescent Biopharma jumps after cancer drug partnership

BRIEF-Invion Secures Exclusive Perpetual Global Rights For Photosoft

BUZZ-Australia's Invion gains on new medical technology license

Invion Ltd - Secures Exclusive Perpetual Global Rights for Photosoft

THOMSON REUTERS

Invion Ltd - Photosoft Licenses Cover Cancers and Infectious Diseases

THOMSON REUTERS

Invion Ltd-Funded Collaboration Agreement With Protect Animal Health

THOMSON REUTERS

Invion Raises About AU$800,000 via Convertible Notes Issue; Shares Rise 5%

MT Newswires Live

BRIEF-Invion Ltd Seeks Trading Halt Pending Capital Raising Announcement

BRIEF-Invion Ltd Post FY Loss Attributable A$8.8 Million

Invion Ltd - Loss for Year Attributable a$8.8 Mln

THOMSON REUTERS

BRIEF-Invion Says Orphan Drug Designation Granted By U.S. FDA For Anal Cancer

Invion Ltd - Orphan Drug Designation Granted by U.S. FDA for Anal Cancer

THOMSON REUTERS

BRIEF-Invion Seeks Trading Halt

Invion Ltd - Seeks Trading Halt Pending Announcement on Development of Photosofttm Technology

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/IVX.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IVX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IVX.AU\",,,,,undefined,":{"symbol":"IVX.AU","market":"AU","secType":"STK","nameCN":"INVION LTD","latestPrice":0.083,"timestamp":1770700320000,"preClose":0.083,"halted":0,"volume":43282,"delay":0,"changeRate":0,"nameEN":"INVION LTD","floatShares":56741426,"shares":85647255,"eps":-0.122249,"marketStatus":"Not Yet Opened","change":0,"latestTime":"02-10 16:12:00 AEDT","open":0.087,"high":0.087,"low":0.082,"amount":3592,"amplitude":0.060241,"askPrice":0.087,"askSize":154172,"bidPrice":0.082,"bidSize":12195,"shortable":3,"etf":0,"ttmEps":-0.122249,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.083,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0.781757,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IVX.AU\",,,,,undefined,":{"symbol":"IVX.AU","floatShares":56741426,"roa":"-44.16%","roe":"-77.64%","lyrEps":-0.122249,"volumeRatio":0.781757,"shares":85647255,"dividePrice":0,"high":0.087,"amplitude":0.060241,"preClose":0.083,"low":0.082,"week52Low":0.075,"pbRate":"0.86","psRate":"2357.79","week52High":0.2,"institutionHeld":0,"latestPrice":0.083,"committee":-0.853396,"eps":-0.122249,"divideRate":0,"volume":43282,"delay":0,"ttmEps":-0.122249,"open":0.087,"prevYearClose":0.093,"prevWeekClose":0.085,"prevMonthClose":0.092,"prevQuarterClose":0.093,"fiveDayClose":0.084,"twentyDayClose":0.092,"sixtyDayClose":0.081},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IVX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-11-20","symbol":"IVX.AU","defaultRemindTime":1732057200000,"type":"split","dateTimestamp":1732021200000,"forFactor":100,"toFactor":1,"ratio":100}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IVX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IVX.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2607091466","title":"BRIEF-Invion Raises A$1.3 Million Through Convertible Note Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2607091466","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607091466?lang=en_us&edition=fundamental","pubTime":"2026-01-30 15:25","pubTimestamp":1769757901,"startTime":"0","endTime":"0","summary":"BRIEF-Invion Raises A$1.3 Million Through Convertible Note OfferingJan 30 (Reuters) - Invion Ltd IVX.AX:RAISED A$1.3 MILLION VIA CONVERTIBLE NOTE OFFERINGFurther company coverage: IVX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nFWN3YV00Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7509","BK7508","BK7096","IVX.AU"],"gpt_icon":0},{"id":"2607409154","title":"Invion Ltd - Raised a$1.3 Mln via Convertible Note Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2607409154","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607409154?lang=en_us&edition=fundamental","pubTime":"2026-01-30 15:16","pubTimestamp":1769757374,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nFWN3YV00Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","BK7508","BK7096","IVX.AU"],"gpt_icon":0},{"id":"2607072065","title":"BRIEF-Invion Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2607072065","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607072065?lang=en_us&edition=fundamental","pubTime":"2026-01-29 09:21","pubTimestamp":1769649671,"startTime":"0","endTime":"0","summary":"BRIEF-Invion Seeks Trading HaltJan 29 (Reuters) - Invion Ltd IVX.AX:SEEKS TRADING HALT PENDING ANNOUNCEMENT ON CAPITAL RAISINGFurther company coverage: IVX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nFWN3YT170:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7509","IVX.AU","BK7096"],"gpt_icon":0},{"id":"2593645408","title":"BRIEF-Invion Secures Non-Dilutive Funding From Hanlim Pharm And Korean Government Research Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=2593645408","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593645408?lang=en_us&edition=fundamental","pubTime":"2025-12-23 09:14","pubTimestamp":1766452465,"startTime":"0","endTime":"0","summary":"BRIEF-Invion Secures Non-Dilutive Funding From Hanlim Pharm And Korean Government Research FundDec 23  - Invion Ltd IVX.AX:NON-DILUTIVE FUNDING SECURED FROM HANLIM PHARM AND KOREAN GOVERNMENT RESEARCH FUND FOR ESOPHAGEAL CANCER PRECLINICAL PROGRAMWORK PROGRAM ESTIMATED TO BE WORTH UP TO A$2 MILLIONFurther company coverage: IVX.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251223:nFWN3XS0AN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7096","BK7508","BK7509","IVX.AU"],"gpt_icon":0},{"id":"2593551544","title":"Invion Ltd -  Work Program Estimated to Be Worth up to a$2 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2593551544","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593551544?lang=en_us&edition=fundamental","pubTime":"2025-12-23 06:38","pubTimestamp":1766443118,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XS0AN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","IVX.AU","BK7509","BK7096"],"gpt_icon":0},{"id":"2593455159","title":"Invion Ltd - Non-Dilutive Funding Secured From Hanlim Pharm and Korean Govt Research Fund for Esophageal Cancer Preclinical Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2593455159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593455159?lang=en_us&edition=fundamental","pubTime":"2025-12-23 06:38","pubTimestamp":1766443118,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nFWN3XS0AN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","BK7508","BK7096","IVX.AU"],"gpt_icon":0},{"id":"2588888137","title":"BUZZ-Crescent Biopharma jumps after cancer drug partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=2588888137","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588888137?lang=en_us&edition=fundamental","pubTime":"2025-12-04 20:24","pubTimestamp":1764851056,"startTime":"0","endTime":"0","summary":"BUZZ-Crescent Biopharma jumps after cancer drug partnership ** Shares of drugmaker Crescent Biopharma CBIO.O rise 36.5% to $18.30 premarket ** Co says it has formed an exclusive partnership with China's Kelun-Biotech to develop and market new cancer treatments** Co is also raising $185 million from investors to fund clinical trials - CBIO** Says deal gives Kelun-Biotech rights to co's experimental drug CR-001 in Greater China** CBIO's CR-001 aims to boost immune response and block blood supply to tumors; SKB105 targets solid tumors, co says** Both firms plan to test drugs alone and in combination; human trials for 3 drugs set for 2026, co says** Up to last close, stock was down ~46% YTD   ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nL4N3XA0UJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["002422","CBIO","LU1979443071.USD","BK1161","BK0239","BK7509","IVX.AU","LU2148510915.USD","LU1934453819.USD","LU0196878994.USD","LU1064131003.USD","BK7096","BK0060","BK4139","BK7508","LU1064130708.USD","06990"],"gpt_icon":0},{"id":"2588109874","title":"BRIEF-Invion Secures Exclusive Perpetual Global Rights For Photosoft","url":"https://stock-news.laohu8.com/highlight/detail?id=2588109874","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588109874?lang=en_us&edition=fundamental","pubTime":"2025-12-03 09:20","pubTimestamp":1764724854,"startTime":"0","endTime":"0","summary":"BRIEF-Invion Secures Exclusive Perpetual Global Rights For PhotosoftDec 3 (Reuters) - Invion Ltd IVX.AX:SECURES EXCLUSIVE PERPETUAL GLOBAL RIGHTS FOR PHOTOSOFTPHOTOSOFT LICENSES COVER CANCERS AND INFECTIOUS DISEASESFurther company coverage: IVX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nFWN3X80XZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVX.AU","BK7508","BK7509","BK7096"],"gpt_icon":0},{"id":"2588067626","title":"BUZZ-Australia's Invion gains on new medical technology license","url":"https://stock-news.laohu8.com/highlight/detail?id=2588067626","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588067626?lang=en_us&edition=fundamental","pubTime":"2025-12-03 08:13","pubTimestamp":1764720816,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Invion gains on new medical technology license** Shares of Invion IVX.AX rise as much as 39.2% to A$0.110, rising most since August 19** Biotech co secures an expanded portfolio of pe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nL4N3X900P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVX.AU","BK7509","BK7096","BK7508"],"gpt_icon":0},{"id":"2588506945","title":"Invion Ltd - Secures Exclusive Perpetual Global Rights for Photosoft","url":"https://stock-news.laohu8.com/highlight/detail?id=2588506945","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588506945?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:44","pubTimestamp":1764711855,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nFWN3X80XZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IVX.AU","BK7508","BK7509","BK7096"],"gpt_icon":0},{"id":"2588453069","title":"Invion Ltd - Photosoft Licenses Cover Cancers and Infectious Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2588453069","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588453069?lang=en_us&edition=fundamental","pubTime":"2025-12-03 05:44","pubTimestamp":1764711855,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nFWN3X80XZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","IVX.AU","BK7096","BK7509"],"gpt_icon":0},{"id":"2577910658","title":"Invion Ltd-Funded Collaboration Agreement With Protect Animal Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2577910658","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577910658?lang=en_us&edition=fundamental","pubTime":"2025-10-21 06:42","pubTimestamp":1761000148,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251020:nTUE1JXFS1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IVX.AU","BK7096","BK7509","BK7508"],"gpt_icon":0},{"id":"2574110753","title":"Invion Raises About AU$800,000 via Convertible Notes Issue; Shares Rise 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2574110753","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574110753?lang=en_us&edition=fundamental","pubTime":"2025-10-10 11:09","pubTimestamp":1760065767,"startTime":"0","endTime":"0","summary":"Invion  raised AU$782,254 through the issue of convertible notes, with an AU$11 face value, to funds and sophisticated investors, according to a Friday filing with the Australian bourse.The notes will be converted into shares at a price of AU$0.11 or the greater of AU$0.07 or 80% of the 15-day volume-weighted average price as of Feb. 28, 2026, the filing said.The notes will mature on either the date on which the agreement is signed or on Feb. 28, 2026, the filing added.Shares of the company rose 5% in recent Friday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7096","BK7509","IVX.AU","BK7508"],"gpt_icon":0},{"id":"2573991287","title":"BRIEF-Invion Ltd Seeks Trading Halt Pending Capital Raising Announcement","url":"https://stock-news.laohu8.com/highlight/detail?id=2573991287","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573991287?lang=en_us&edition=fundamental","pubTime":"2025-10-08 06:36","pubTimestamp":1759876593,"startTime":"0","endTime":"0","summary":"BRIEF-Invion Ltd Seeks Trading Halt Pending Capital Raising AnnouncementOct 8 (Reuters) - Invion Ltd IVX.AX:SEEKS TRADING HALT PENDING CAPITAL RAISING ANNOUNCEMENTFurther company coverage: IVX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251007:nFWN3VO2PR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","BK7509","IVX.AU"],"gpt_icon":0},{"id":"2562576792","title":"BRIEF-Invion Ltd Post FY Loss Attributable A$8.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2562576792","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562576792?lang=en_us&edition=fundamental","pubTime":"2025-08-27 09:55","pubTimestamp":1756259716,"startTime":"0","endTime":"0","summary":"BRIEF-Invion Ltd Post FY Loss Attributable A$8.8 MillionAug 27 (Reuters) - Invion Ltd IVX.AX:LOSS FOR YEAR ATTRIBUTABLE A$8.8 MILLIONFurther company coverage: IVX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nFWN3UI0TR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVX.AU","BK7509","BK7508","BK7096"],"gpt_icon":0},{"id":"2562276487","title":"Invion Ltd - Loss for Year Attributable a$8.8 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2562276487","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2562276487?lang=en_us&edition=fundamental","pubTime":"2025-08-27 08:56","pubTimestamp":1756256206,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250827:nFWN3UI0TR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7096","BK7509","IVX.AU"],"gpt_icon":0},{"id":"2560144678","title":"BRIEF-Invion Says Orphan Drug Designation Granted By U.S. FDA For Anal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2560144678","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560144678?lang=en_us&edition=fundamental","pubTime":"2025-08-20 09:27","pubTimestamp":1755653220,"startTime":"0","endTime":"0","summary":"BRIEF-Invion Says Orphan Drug Designation Granted By U.S. FDA For Anal CancerAug 20 (Reuters) - Invion Ltd IVX.AX:ORPHAN DRUG DESIGNATION GRANTED BY U.S. FDA FOR ANAL CANCERFurther company coverage: IVX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250820:nFWN3UB0V9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7096","BK7509","IVX.AU"],"gpt_icon":0},{"id":"2560145782","title":"Invion Ltd - Orphan Drug Designation Granted by U.S. FDA for Anal Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2560145782","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560145782?lang=en_us&edition=fundamental","pubTime":"2025-08-20 07:50","pubTimestamp":1755647425,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nFWN3UB0V9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","BK7096","IVX.AU","BK7508"],"gpt_icon":0},{"id":"2560494163","title":"BRIEF-Invion Seeks Trading Halt","url":"https://stock-news.laohu8.com/highlight/detail?id=2560494163","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560494163?lang=en_us&edition=fundamental","pubTime":"2025-08-19 15:23","pubTimestamp":1755588184,"startTime":"0","endTime":"0","summary":"BRIEF-Invion Seeks Trading Halt Aug 19 (Reuters) - Invion Ltd IVX.AX:SEEKS TRADING HALT PENDING ANNOUNCEMENT ON  DEVELOPMENT OF PHOTOSOFTTM TECHNOLOGYFurther company coverage: IVX.AX ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nFWN3UB08Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IVX.AU","BK7096","BK7509","BK7508"],"gpt_icon":0},{"id":"2560163480","title":"Invion Ltd - Seeks Trading Halt Pending Announcement on  Development of Photosofttm Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2560163480","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2560163480?lang=en_us&edition=fundamental","pubTime":"2025-08-19 15:22","pubTimestamp":1755588161,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250819:nFWN3UB08Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7509","BK7508","BK7096","IVX.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}]}}